Earns most awards globally with wins in 16 categories
TORONTO, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Leading global diversified professional services company Colliers (NASDAQ and TSX: CIGI) is proud to...
VANCOUVER, British Columbia, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherap...
Ziihera is the first and only dual HER2-targeted bispecific antibody approved for HER2-positive BTC in the U.S.
Ziihera received accelerated approval based on results including a 52% objective re...
Nov. 21, 2024
Industry’s first wide bore, high-performance helium-free [1] 1.5T MR features AI assistance at every step in the MRI workflow, with seamless integration of cloud-based AI image rea...
